Deals Shaping the Medical Industry, August 2017

16 Aug 2017

• By Beth Allan, Deanna Kamienski, Maureen Riordan, Amanda Micklus, and Steven Muntner

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced July 2017.

Quidel Corp. is acquiring Alere's Triage MeterPro cardiovascular and toxicology assets and the Triage B-type naturietic peptide (BNP) assay business. (Jul.)

For both, Quidel will shell out $400mm plus $40mm in contingent payments payable in five installments of $8mm. The company...